Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Loss of TP53 as a prognostic biomarker of poor survival in stage III colorectal cancer patients. Nadauld, L., Van Hummelen, P., Xia, L., Day, K., Lee, H., Bell, J., Grimes, S. M., Kubit, M., Miller, M., Shin, G., Wood, C., Greer, S., Escobar, H., Haslem, D. S., Ji, H. AMER SOC CLINICAL ONCOLOGY. 2018
View details for DOI 10.1200/JCO.2018.36.15_suppl.e15588
View details for Web of Science ID 000442916005065